Evaluation of POCs Devices for Monitoring CNCDs (PR)
Research type
Research Study
Full title
Evaluation of Point of Care Devices for Monitoring of Chronic Non-Communicable Diseases
IRAS ID
212214
Contact name
Iain Chapple
Contact email
Sponsor organisation
University of Birmingham
Duration of Study in the UK
1 years, 1 months, 1 days
Research summary
The prevalence of chronic non-communicable diseases (CNCD) is increasing globally and their impact on the global disease burden and healthcare economy is substantial. Severe Chronic Kidney Disease (CKD) is a major global public health problem due to the costs of providing renal support such as dialysis. Early identification and successful monitoring is key to providing effective CKD treatments. This study is examining whether monitoring of creatinine (a protein in the blood that is a useful marker of kidney function) using a point of care testing device (a finger-prick) is as good as a full blood test in assessing kidney function. The second point of care machine (DCA Vantage) tests for HbA1C levels which will screen for diabetes. If the DCA Vantage shows that finger prick tests accurately correlate to our existing laboratory methods, Point-of-care (POC) testing may be utilised chairside, producing immediate results, therefore allowing more streamlined patient care and earlier intervention. The study will recruit patients from the Renal Medicine Department and the Diabetes Unit at the Queen Elizabeth Hospital in Birmingham, respectively.
REC name
South East Scotland REC 01
REC reference
16/SS/0197
Date of REC Opinion
4 Nov 2016
REC opinion
Favourable Opinion